Boule Diagnostics AB BOUL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 10.91
- Price/Sales
- 0.61
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The firm focuses on the decentralized market segment. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. Through its subsidiaries, the Group operates in Sweden, USA, and China.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 230
- Website
- https://www.boule.com
Comparables
Valuation
|
Metric
|
BOUL
|
SVOL A
|
MCAP
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.91 | 20.42 | 37.07 |
Price/Book Value | 0.70 | 1.59 | 6.41 |
Price/Sales | 0.61 | 8.41 | 4.25 |
Price/Cash Flow | 7.86 | 115.31 | 24.55 |
Price/Earnings
BOUL
SVOL A
MCAP
Financial Strength
|
Metric
|
BOUL
|
SVOL A
|
MCAP
|
|---|---|---|---|
Quick Ratio | 0.93 | — | 1.62 |
Current Ratio | 1.23 | — | 2.39 |
Interest Coverage | 2.97 | — | 16.12 |
Quick Ratio
BOUL
SVOL A
MCAP
Profitability
|
Metric
|
BOUL
|
SVOL A
|
MCAP
|
|---|---|---|---|
Return on Assets (Normalized) | 2.70% | 8.59% | 12.60% |
Return on Equity (Normalized) | 4.35% | 8.63% | 20.57% |
Return on Invested Capital (Normalized) | 4.25% | — | 16.61% |
Return on Assets
BOUL
SVOL A
MCAP
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Ntfrcppt | Ttrzwbt | $195.9 Bil | |||
| Stryker Corp
SYK
| Ghfbhtvkx | Nmk | $137.0 Bil | |||
| Boston Scientific Corp
BSX
| Bcbblxyv | Jgnnc | $123.0 Bil | |||
| Medtronic PLC
MDT
| Gmnyfglz | Dgqywc | $114.7 Bil | |||
| Edwards Lifesciences Corp
EW
| Qwnlllzfc | Fkmzxhf | $39.4 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Tgp | Vdgrw | $29.1 Bil | |||
| DexCom Inc
DXCM
| Nsnxnbbnv | Ynmry | $26.7 Bil | |||
| Steris PLC
STE
| Fjsgnzdtq | Cdjfnn | $23.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Xldcjrrpsz | Mtz | $21.7 Bil | |||
| Insulet Corp
PODD
| Cymxhbmsv | Plfxfg | $16.7 Bil |
United States